Patent assignee · SE · COMPANY

ALBIREO AB

56Patents
53Active
56Granted
55Portfolio score

Filing activity: Feb 23, 2004 → Jun 2, 2023 · 3 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7514421B2 Use of an IBAT inhibitor for the treatment of constipation Human Necessities 71 Expired
US8067584B2 Benzothiazepine derivatives Chemistry; Metallurgy 65 Expired
US9694018B1 IBAT inhibitors for the treatment of liver disease Human Necessities 43 Active
US11014898B1 Benzothiazepine compounds and their use as bile acid modulators Human Necessities 26 Active
US11111224B2 Benzothia(di)azepine compounds and their use as bile acid modulators Chemistry; Metallurgy 25 Active
US9688720B2 IBAT inhibitors for the treatment of liver diseases Human Necessities 24 Active
US10941127B2 Benzothiadiazepine compounds and their use as bile acid modulators Human Necessities 21 Active
US10093697B2 IBAT inhibitors for the treatment of liver diseases Human Necessities 20 Active
US10487111B2 IBAT inhibitors for the treatment of liver diseases Human Necessities 19 Active
US11180465B2 Benzothia(di)azepine compounds and their use as bile acid modulators Chemistry; Metallurgy 19 Active
US11225466B2 Benzothiadiazepine compounds and their use as bile acid modulators Human Necessities 18 Active
US10975046B2 Crystal modifications of odevixibat Emerging Cross-Sectional Technologies 17 Active
US10011633B2 IBAT inhibitors for the treatment of liver diseases Human Necessities 16 Active
US10793534B2 Benzothia(di)azepine compounds and their use as bile acid modulators Chemistry; Metallurgy 16 Active
US10981952B2 IBAT inhibitors for the treatment of liver diseases Human Necessities 16 Active
US10000528B2 IBAT inhibitors for the treatment of liver diseases Human Necessities 15 Active
US11267794B2 Benzothia(di)azepine compounds and their use as bile acid modulators Chemistry; Metallurgy 15 Active
US11261212B2 IBAT inhibitors for the treatment of liver diseases Human Necessities 13 Active
US11306064B2 Benzothia(di)azepine compounds and their use as bile acid modulators Chemistry; Metallurgy 12 Active
US11572350B1 Benzothia(di)azepine compounds and their use as bile acid modulators Chemistry; Metallurgy 12 Active
US10786529B2 Oral cholestyramine formulation and use thereof Human Necessities 11 Active
US11773071B2 Benzothiazepine compounds and their use as bile acid modulators Human Necessities 9 Active
US11377429B2 Benzothia(di)azepine compounds and their use as bile acid modulators Human Necessities 9 Active
US11603359B2 Benzothiadiazepine compounds and their use as bile acid modulators Human Necessities 8 Active
US11801226B2 Pharmaceutical formulation of odevixibat Chemistry; Metallurgy 8 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.